{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T19:52:09Z","timestamp":1771617129824,"version":"3.50.1"},"publisher-location":"Cham","reference-count":129,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319717784","type":"print"},{"value":"9783319717791","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-71779-1_3","type":"book-chapter","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T09:51:01Z","timestamp":1518169861000},"page":"59-83","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":160,"title":["Mitochondrial Dysfunction in Huntington\u2019s Disease"],"prefix":"10.1007","author":[{"given":"Catarina","family":"Carmo","sequence":"first","affiliation":[]},{"given":"Luana","family":"Naia","sequence":"additional","affiliation":[]},{"given":"Carla","family":"Lopes","sequence":"additional","affiliation":[]},{"given":"A. Cristina","family":"Rego","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2018,2,10]]},"reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2013.03.018","volume":"63","author":"RK Chaturvedi","year":"2013","unstructured":"Chaturvedi RK, Flint Beal M (2013) Mitochondrial diseases of the brain. Free Radic Biol Med 63:1\u201329","journal-title":"Free Radic Biol Med"},{"key":"3_CR2","unstructured":"Collaborative THsD (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. In Cell 971\u2013983"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","volume":"19","author":"J Kim","year":"2010","unstructured":"Kim J, Moody JP, Edgerly CK, Bordiuk OL, Cormier K, Smith K, Beal MF, Ferrante RJ (2010) Mitochondrial loss, dysfunction and altered dynamics in Huntington\u2019s disease. Hum Mol Genet 19:3919\u20133935","journal-title":"Hum Mol Genet"},{"key":"3_CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0304-3940(97)00482-5","volume":"231","author":"MH Kodsi","year":"1997","unstructured":"Kodsi MH, Swerdlow NR (1997) Mitochondrial toxin 3-nitropropionic acid produces startle reflex abnormalities and striatal damage in rats that model some features of Huntington\u2019s disease. Neurosci Lett 231:103\u2013107","journal-title":"Neurosci Lett"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/mds.20373","volume":"20","author":"C Saft","year":"2005","unstructured":"Saft C, Zange J, Andrich J, Muller K, Lindenberg K, Landwehrmeyer B, Vorgerd M, Kraus PH, Przuntek H, Schols L (2005) Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington\u2019s disease. Mov Disord Off J Mov Disord Soc 20:674\u2013679","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"3_CR6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1212\/WNL.28.1.23","volume":"28","author":"HH Goebel","year":"1978","unstructured":"Goebel HH, Heipertz R, Scholz W, Iqbal K, Tellez-Nagel I (1978) Juvenile Huntington chorea: clinical, ultrastructural, and biochemical studies. Neurology 28:23\u201331","journal-title":"Neurology"},{"key":"3_CR7","doi-asserted-by":"crossref","first-page":"4181","DOI":"10.1523\/JNEUROSCI.13-10-04181.1993","volume":"13","author":"MF Beal","year":"1993","unstructured":"Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci Off J Soc Neurosci 13:4181\u20134192","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","volume":"92","author":"E Brouillet","year":"1995","unstructured":"Brouillet E, Hantraye P, Ferrante RJ, Dolan R, Leroy-Willig A, Kowall NW, Beal MF (1995) Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci USA 92:7105\u20137109","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","volume":"39","author":"M Gu","year":"1996","unstructured":"Gu M, Gash MT, Mann VM, Javoy-Agid F, Cooper JM, Schapira AH (1996) Mitochondrial defect in Huntington\u2019s disease caudate nucleus. Ann Neurol 39:385\u2013389","journal-title":"Ann Neurol"},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/hmg\/ddh162","volume":"13","author":"YS Choo","year":"2004","unstructured":"Choo YS, Johnson GV, MacDonald M, Detloff PJ, Lesort M (2004) Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum Mol Genet 13:1407\u20131420","journal-title":"Hum Mol Genet"},{"key":"3_CR11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","volume":"5","author":"AV Panov","year":"2002","unstructured":"Panov AV, Gutekunst CA, Leavitt BR, Hayden MR, Burke JR, Strittmatter WJ, Greenamyre JT (2002) Early mitochondrial calcium defects in Huntington\u2019s disease are a direct effect of polyglutamines. Nat Neurosci 5:731\u2013736","journal-title":"Nat Neurosci"},{"key":"3_CR12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","volume":"17","author":"W Song","year":"2011","unstructured":"Song W, Chen J, Petrilli A, Liot G, Klinglmayr E, Zhou Y, Poquiz P, Tjong J, Pouladi MA, Hayden MR et al (2011) Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med 17:377\u2013382","journal-title":"Nat Med"},{"key":"3_CR13","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/hmg\/dds503","volume":"22","author":"E Napoli","year":"2013","unstructured":"Napoli E, Wong S, Hung C, Ross-Inta C, Bomdica P, Giulivi C (2013) Defective mitochondrial disulfide relay system, altered mitochondrial morphology and function in Huntington\u2019s disease. Hum Mol Genet 22:989\u20131004","journal-title":"Hum Mol Genet"},{"key":"3_CR14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.mad.2005.09.010","volume":"127","author":"F Squitieri","year":"2006","unstructured":"Squitieri F, Cannella M, Sgarbi G, Maglione V, Falleni A, Lenzi P, Baracca A, Cislaghi G, Saft C, Ragona G et al (2006) Severe ultrastructural mitochondrial changes in lymphoblasts homozygous for Huntington disease mutation. Mech Ageing Dev 127:217\u2013220","journal-title":"Mech Ageing Dev"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nn.3721","volume":"17","author":"H Yano","year":"2014","unstructured":"Yano H, Baranov SV, Baranova OV, Kim J, Pan Y, Yablonska S, Carlisle DL, Ferrante RJ, Kim AH, Friedlander RM (2014) Inhibition of mitochondrial protein import by mutant huntingtin. Nat Neurosci 17:822\u2013831","journal-title":"Nat Neurosci"},{"issue":"4","key":"3_CR16","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0166-2236(99)01534-9","volume":"23","author":"David G. Nicholls","year":"2000","unstructured":"Nicholls DG, Ward MW (2000) Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends Neurosci 23(4):166\u2013174","journal-title":"Trends in Neurosciences"},{"key":"3_CR17","doi-asserted-by":"crossref","first-page":"34785","DOI":"10.1074\/jbc.M603845200","volume":"281","author":"T Milakovic","year":"2006","unstructured":"Milakovic T, Quintanilla RA, Johnson GV (2006) Mutant huntingtin expression induces mitochondrial calcium handling defects in clonal striatal cells: functional consequences. J Biol Chem 281:34785\u201334795","journal-title":"J Biol Chem"},{"key":"3_CR18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s12035-014-8735-4","volume":"51","author":"L Naia","year":"2015","unstructured":"Naia L, Ferreira IL, Cunha-Oliveira T, Duarte AI, Ribeiro M, Rosenstock TR, Laco MN, Ribeiro MJ, Oliveira CR, Saudou F et al (2015) Activation of IGF-1 and insulin signaling pathways ameliorate mitochondrial function and energy metabolism in Huntington\u2019s Disease human lymphoblasts. Mol Neurobiol 51:331\u2013348","journal-title":"Mol Neurobiol"},{"key":"3_CR19","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/13518","volume":"5","author":"A Sawa","year":"1999","unstructured":"Sawa A, Wiegand GW, Cooper J, Margolis RL, Sharp AH, Lawler JF Jr, Greenamyre JT, Snyder SH, Ross CA (1999) Increased apoptosis of Huntington disease lymphoblasts associated with repeat length-dependent mitochondrial depolarization. Nat Med 5:1194\u20131198","journal-title":"Nat Med"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbrc.2008.07.009","volume":"374","author":"S Almeida","year":"2008","unstructured":"Almeida S, Sarmento-Ribeiro AB, Januario C, Rego AC, Oliveira CR (2008) Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington\u2019s disease patients. Biochem Biophys Res Commun 374:599\u2013603","journal-title":"Biochem Biophys Res Commun"},{"key":"3_CR21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.expneurol.2010.01.002","volume":"222","author":"IL Ferreira","year":"2010","unstructured":"Ferreira IL, Nascimento MV, Ribeiro M, Almeida S, Cardoso SM, Grazina M, Pratas J, Santos MJ, Januario C, Oliveira CR et al (2010) Mitochondrial-dependent apoptosis in Huntington\u2019s disease human cybrids. Exp Neurol 222:243\u2013255","journal-title":"Exp Neurol"},{"key":"3_CR22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","volume":"2","author":"S Humbert","year":"2002","unstructured":"Humbert S, Bryson EA, Cordelieres FP, Connors NC, Datta SR, Finkbeiner S, Greenberg ME, Saudou F (2002) The IGF-1\/Akt pathway is neuroprotective in Huntington\u2019s disease and involves Huntingtin phosphorylation by Akt. Dev Cell 2:831\u2013837","journal-title":"Dev Cell"},{"key":"3_CR23","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1091\/mbc.E05-07-0607","volume":"17","author":"A Benchoua","year":"2006","unstructured":"Benchoua A, Trioulier Y, Zala D, Gaillard MC, Lefort N, Dufour N, Saudou F, Elalouf JM, Hirsch E, Hantraye P et al (2006) Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin. Mol Biol Cell 17:1652\u20131663","journal-title":"Mol Biol Cell"},{"key":"3_CR24","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1196\/annals.1427.018","volume":"1147","author":"SE Browne","year":"2008","unstructured":"Browne SE (2008) Mitochondria and Huntington\u2019s disease pathogenesis: insight from genetic and chemical models. Ann N Y Acad Sci 1147:358\u2013382","journal-title":"Ann N Y Acad Sci"},{"key":"3_CR25","first-page":"237","volume":"58","author":"ID Maksimovic","year":"2001","unstructured":"Maksimovic ID, Jovanovic MD, Colic M, Mihajlovic R, Micic D, Selakovic V, Ninkovic M, Malicevic Z, Rusic-Stojiljkovic M, Jovicic A (2001) Oxidative damage and metabolic dysfunction in experimental Huntington\u2019s disease: selective vulnerability of the striatum and hippocampus. Vojnosanit Pregl 58:237\u2013242","journal-title":"Vojnosanit Pregl"},{"key":"3_CR26","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1471-4159.2007.04996.x","volume":"104","author":"M Pandey","year":"2008","unstructured":"Pandey M, Varghese M, Sindhu KM, Sreetama S, Navneet AK, Mohanakumar KP, Usha R (2008) Mitochondrial NAD\u00a0+\u00a0-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington\u2019s disease. J Neurochem 104:420\u2013434","journal-title":"J Neurochem"},{"key":"3_CR27","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.mito.2013.05.006","volume":"13","author":"AC Silva","year":"2013","unstructured":"Silva AC, Almeida S, Laco M, Duarte AI, Domingues J, Oliveira CR, Januario C, Rego AC (2013) Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington\u2019s disease carriers. Mitochondrion 13:801\u2013809","journal-title":"Mitochondrion"},{"key":"3_CR28","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11010-013-1951-9","volume":"389","author":"J Chakraborty","year":"2014","unstructured":"Chakraborty J, Rajamma U, Mohanakumar KP (2014) A mitochondrial basis for Huntington\u2019s disease: therapeutic prospects. Mol Cell Biochem 389:277\u2013291","journal-title":"Mol Cell Biochem"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1471-4159.2006.04361.x","volume":"101","author":"JM Oliveira","year":"2007","unstructured":"Oliveira JM, Jekabsons MB, Chen S, Lin A, Rego AC, Goncalves J, Ellerby LM, Nicholls DG (2007) Mitochondrial dysfunction in Huntington\u2019s disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice. J Neurochem 101:241\u2013249","journal-title":"J Neurochem"},{"key":"3_CR30","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1111\/j.1471-4159.2005.03036.x","volume":"93","author":"N Brustovetsky","year":"2005","unstructured":"Brustovetsky N, LaFrance R, Purl KJ, Brustovetsky T, Keene CD, Low WC, Dubinsky JM (2005) Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington\u2019s Disease. J Neurochem 93:1361\u20131370","journal-title":"J Neurochem"},{"key":"3_CR31","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/jnc.13165","volume":"134","author":"JJ Pellman","year":"2015","unstructured":"Pellman JJ, Hamilton J, Brustovetsky T, Brustovetsky N (2015) Ca(2+) handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington\u2019s disease. J Neurochem 134:652\u2013667","journal-title":"J Neurochem"},{"issue":"2","key":"3_CR32","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","volume":"11","author":"The\u00a0HD\u00a0iPSC\u00a0Consortium","year":"2012","unstructured":"HD iPSC Consortium (2012) Induced pluripotent stem cells from patients with Huntington\u2019s disease show CAG-repeat-expansion-associated phenotypes. Cell stem cell 11:264\u2013278","journal-title":"Cell Stem Cell"},{"key":"3_CR33","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/mds.25009","volume":"27","author":"F Mochel","year":"2012","unstructured":"Mochel F, N\u2019Guyen TM, Deelchand D, Rinaldi D, Valabregue R, Wary C, Carlier PG, Durr A, Henry PG (2012) Abnormal response to cortical activation in early stages of Huntington disease. Movement disorders: official journal of the Movement Disorder Society 27:907\u2013910","journal-title":"Movement disorders: official journal of the Movement Disorder Society"},{"key":"3_CR34","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1007\/s12035-013-8585-5","volume":"49","author":"C Lopes","year":"2014","unstructured":"Lopes C, Ribeiro M, Duarte AI, Humbert S, Saudou F, Pereira de Almeida L, Hayden M, Rego AC (2014) IGF-1 intranasal administration rescues Huntington\u2019s disease phenotypes in YAC128 mice. Mol Neurobiol 49:1126\u20131142","journal-title":"Mol Neurobiol"},{"key":"3_CR35","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1074\/jbc.M111.309849","volume":"287","author":"F Mochel","year":"2012","unstructured":"Mochel F, Durant B, Meng X, O\u2019Callaghan J, Yu H, Brouillet E, Wheeler VC, Humbert S, Schiffmann R, Durr A (2012) Early alterations of brain cellular energy homeostasis in Huntington disease models. J Biol Chem 287:1361\u20131370","journal-title":"J Biol Chem"},{"key":"3_CR36","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1093\/hmg\/ddi319","volume":"14","author":"IS Seong","year":"2005","unstructured":"Seong IS, Ivanova E, Lee JM, Choo YS, Fossale E, Anderson M, Gusella JF, Laramie JM, Myers RH, Lesort M et al (2005) HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism. Hum Mol Genet 14:2871\u20132880","journal-title":"Hum Mol Genet"},{"key":"3_CR37","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000321681","volume":"8","author":"SF Zhang","year":"2011","unstructured":"Zhang SF, Hennessey T, Yang L, Starkova NN, Beal MF, Starkov AA (2011) Impaired brain creatine kinase activity in Huntington\u2019s disease. Neurodegener Dis 8:194\u2013201","journal-title":"Neurodegener Dis"},{"key":"3_CR38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I","volume":"48","author":"R Lodi","year":"2000","unstructured":"Lodi R, Schapira AH, Manners D, Styles P, Wood NW, Taylor DJ, Warner TT (2000) Abnormal in vivo skeletal muscle energy metabolism in Huntington\u2019s disease and dentatorubropallidoluysian atrophy. Ann Neurol 48:72\u201376","journal-title":"Ann Neurol"},{"key":"3_CR39","doi-asserted-by":"crossref","unstructured":"Naia L, Ribeiro M, Rodrigues J, Duarte AI, Lopes C, Rosenstock TR, Hayden MR, Rego AC (2016) Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin. Neuropeptides","DOI":"10.1016\/j.npep.2016.01.009"},{"issue":"Pt 6","key":"3_CR40","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","volume":"119","author":"A Antonini","year":"1996","unstructured":"Antonini A, Leenders KL, Spiegel R, Meier D, Vontobel P, Weigell-Weber M, Sanchez-Pernaute R, de Yebenez JG, Boesiger P, Weindl A et al (1996) Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington\u2019s disease. Brain A J Neurol 119(Pt 6):2085\u20132095","journal-title":"Brain A J Neurol"},{"key":"3_CR41","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1056\/NEJM198702123160701","volume":"316","author":"JC Mazziotta","year":"1987","unstructured":"Mazziotta JC, Phelps ME, Pahl JJ, Huang SC, Baxter LR, Riege WH, Hoffman JM, Kuhl DE, Lanto AB, Wapenski JA et al (1987) Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington\u2019s disease. The New England journal of medicine 316:357\u2013362","journal-title":"The New England journal of medicine"},{"key":"3_CR42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.nbd.2007.04.008","volume":"27","author":"WJ Powers","year":"2007","unstructured":"Powers WJ, Haas RH, Le T, Videen TO, Hershey T, McGee-Minnich L, Perlmutter JS (2007) Normal platelet mitochondrial complex I activity in Huntington\u2019s disease. Neurobiology of disease 27:99\u2013101","journal-title":"Neurobiology of disease"},{"key":"3_CR43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nm0396-347","volume":"2","author":"JR Burke","year":"1996","unstructured":"Burke JR, Enghild JJ, Martin ME, Jou YS, Myers RM, Roses AD, Vance JM, Strittmatter WJ (1996) Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nat Med 2:347\u2013350","journal-title":"Nat Med"},{"key":"3_CR44","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1093\/hmg\/ddr195","volume":"20","author":"JC Jacobsen","year":"2011","unstructured":"Jacobsen JC, Gregory GC, Woda JM, Thompson MN, Coser KR, Murthy V, Kohane IS, Gusella JF, Seong IS, MacDonald ME et al (2011) HD CAG-correlated gene expression changes support a simple dominant gain of function. Hum Mol Genet 20:2846\u20132860","journal-title":"Hum Mol Genet"},{"key":"3_CR45","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","volume":"43","author":"BG Jenkins","year":"1993","unstructured":"Jenkins BG, Koroshetz WJ, Beal MF, Rosen BR (1993) Evidence for impairment of energy metabolism in vivo in Huntington\u2019s disease using localized 1H NMR spectroscopy. Neurology 43:2689\u20132695","journal-title":"Neurology"},{"key":"3_CR46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.410410206","volume":"41","author":"WJ Koroshetz","year":"1997","unstructured":"Koroshetz WJ, Jenkins BG, Rosen BR, Beal MF (1997) Energy metabolism defects in Huntington\u2019s disease and effects of coenzyme Q10. Ann Neurol 41:160\u2013165","journal-title":"Ann Neurol"},{"key":"3_CR47","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jns.2007.05.035","volume":"263","author":"WR Martin","year":"2007","unstructured":"Martin WR, Wieler M, Hanstock CC (2007) Is brain lactate increased in Huntington\u2019s disease? J Neurol Sci 263:70\u201374","journal-title":"J Neurol Sci"},{"key":"3_CR48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/pr050244o","volume":"5","author":"TM Tsang","year":"2006","unstructured":"Tsang TM, Woodman B, McLoughlin GA, Griffin JL, Tabrizi SJ, Bates GP, Holmes E (2006) Metabolic characterization of the R6\/2 transgenic mouse model of Huntington\u2019s disease by high-resolution MAS 1H NMR spectroscopy. J Proteome Res 5:483\u2013492","journal-title":"J Proteome Res"},{"key":"3_CR49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.expneurol.2011.05.024","volume":"231","author":"IL Ferreira","year":"2011","unstructured":"Ferreira IL, Cunha-Oliveira T, Nascimento MV, Ribeiro M, Proenca MT, Januario C, Oliveira CR, Rego AC (2011) Bioenergetic dysfunction in Huntington\u2019s disease human cybrids. Exp Neurol 231:127\u2013134","journal-title":"Exp Neurol"},{"key":"3_CR50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0022-510X(85)90112-1","volume":"67","author":"J Butterworth","year":"1985","unstructured":"Butterworth J, Yates CM, Reynolds GP (1985) Distribution of phosphate-activated glutaminase, succinic dehydrogenase, pyruvate dehydrogenase and gamma-glutamyl transpeptidase in post-mortem brain from Huntington\u2019s disease and agonal cases. J Neurol Sci 67:161\u2013171","journal-title":"J Neurol Sci"},{"key":"3_CR51","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ana.410130116","volume":"13","author":"S Sorbi","year":"1983","unstructured":"Sorbi S, Bird ED, Blass JP (1983) Decreased pyruvate dehydrogenase complex activity in Huntington and Alzheimer brain. Ann Neurol 13:72\u201378","journal-title":"Ann Neurol"},{"key":"3_CR52","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.1085","volume":"50","author":"OA Andreassen","year":"2001","unstructured":"Andreassen OA, Ferrante RJ, Huang HM, Dedeoglu A, Park L, Ferrante KL, Kwon J, Borchelt DR, Ross CA, Gibson GE et al (2001) Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington\u2019s disease. Ann Neurol 50:112\u2013117","journal-title":"Ann Neurol"},{"key":"3_CR53","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1046\/j.1471-4159.2003.02263.x","volume":"88","author":"P Klivenyi","year":"2004","unstructured":"Klivenyi P, Starkov AA, Calingasan NY, Gardian G, Browne SE, Yang L, Bubber P, Gibson GE, Patel MS, Beal MF (2004) Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity. J Neurochem 88:1352\u20131360","journal-title":"J Neurochem"},{"key":"3_CR54","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","volume":"45","author":"SJ Tabrizi","year":"1999","unstructured":"Tabrizi SJ, Cleeter MW, Xuereb J, Taanman JW, Cooper JM, Schapira AH (1999) Biochemical abnormalities and excitotoxicity in Huntington\u2019s disease brain. Ann Neurol 45:25\u201332","journal-title":"Ann Neurol"},{"key":"3_CR55","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/NEN.0000000000000197","volume":"74","author":"NN Naseri","year":"2015","unstructured":"Naseri NN, Xu H, Bonica J, Vonsattel JP, Cortes EP, Park LC, Arjomand J, Gibson GE (2015) Abnormalities in the tricarboxylic Acid cycle in Huntington disease and in a Huntington disease mouse model. J Neuropathol Exp Neurol 74:527\u2013537","journal-title":"J Neuropathol Exp Neurol"},{"key":"3_CR56","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.freeradbiomed.2010.05.016","volume":"49","author":"MA Sorolla","year":"2010","unstructured":"Sorolla MA, Rodriguez-Colman MJ, Tamarit J, Ortega Z, Lucas JJ, Ferrer I, Ros J, Cabiscol E (2010) Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism. Free Radic Biol Med 49:612\u2013621","journal-title":"Free Radic Biol Med"},{"key":"3_CR57","doi-asserted-by":"crossref","unstructured":"Vinogradov AD, Grivennikova VG (2015) Oxidation of NADH and ROS production by respiratory complex I. Biochim Biophys Acta","DOI":"10.1016\/j.bbabio.2015.11.004"},{"key":"3_CR58","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.bbabio.2012.12.002","volume":"1827","author":"L Bleier","year":"2013","unstructured":"Bleier L, Drose S (2013) Superoxide generation by complex III: from mechanistic rationales to functional consequences. Biochim Biophys Acta 1827:1320\u20131331","journal-title":"Biochim Biophys Acta"},{"key":"3_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","volume":"417","author":"MP Murphy","year":"2009","unstructured":"Murphy MP (2009) How mitochondria produce reactive oxygen species. Biochem J 417:1\u201313","journal-title":"Biochem J"},{"key":"3_CR60","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.freeradbiomed.2013.05.027","volume":"62","author":"JM Flynn","year":"2013","unstructured":"Flynn JM, Melov S (2013) SOD2 in mitochondrial dysfunction and neurodegeneration. Free Radic Biol Med 62:4\u201312","journal-title":"Free Radic Biol Med"},{"key":"3_CR61","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/1615-9861(200109)1:9<1105::AID-PROT1105>3.0.CO;2-M","volume":"1","author":"T Rabilloud","year":"2001","unstructured":"Rabilloud T, Heller M, Rigobello MP, Bindoli A, Aebersold R, Lunardi J (2001) The mitochondrial antioxidant defence system and its response to oxidative stress. Proteomics 1:1105\u20131110","journal-title":"Proteomics"},{"key":"3_CR62","doi-asserted-by":"crossref","first-page":"44512","DOI":"10.1074\/jbc.M111.307587","volume":"286","author":"S Hands","year":"2011","unstructured":"Hands S, Sajjad MU, Newton MJ, Wyttenbach A (2011) In vitro and in vivo aggregation of a fragment of huntingtin protein directly causes free radical production. J Biol Chem 286:44512\u201344520","journal-title":"J Biol Chem"},{"key":"3_CR63","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","volume":"45","author":"MA Sorolla","year":"2008","unstructured":"Sorolla MA, Reverter-Branchat G, Tamarit J, Ferrer I, Ros J, Cabiscol E (2008) Proteomic and oxidative stress analysis in human brain samples of Huntington disease. Free Radic Biol Med 45:667\u2013678","journal-title":"Free Radic Biol Med"},{"key":"3_CR64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/bss0660099","volume":"66","author":"SJ Tabrizi","year":"1999","unstructured":"Tabrizi SJ, Schapira AH (1999) Secondary abnormalities of mitochondrial DNA associated with neurodegeneration. Biochem Soc Symp 66:99\u2013110","journal-title":"Biochem Soc Symp"},{"key":"3_CR65","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/1531-8249(200001)47:1<80::AID-ANA13>3.0.CO;2-K","volume":"47","author":"SJ Tabrizi","year":"2000","unstructured":"Tabrizi SJ, Workman J, Hart PE, Mangiarini L, Mahal A, Bates G, Cooper JM, Schapira AH (2000) Mitochondrial dysfunction and free radical damage in the Huntington R6\/2 transgenic mouse. Ann Neurol 47:80\u201386","journal-title":"Ann Neurol"},{"key":"3_CR66","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2014.06.023","volume":"74","author":"M Ribeiro","year":"2014","unstructured":"Ribeiro M, Rosenstock TR, Oliveira AM, Oliveira CR, Rego AC (2014) Insulin and IGF-1 improve mitochondrial function in a PI-3\u00a0K\/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington\u2019s disease knock-in striatal cells. Free Radic Biol Med 74:129\u2013144","journal-title":"Free Radic Biol Med"},{"key":"3_CR67","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.freeradbiomed.2012.09.004","volume":"53","author":"M Ribeiro","year":"2012","unstructured":"Ribeiro M, Rosenstock TR, Cunha-Oliveira T, Ferreira IL, Oliveira CR, Rego AC (2012) Glutathione redox cycle dysregulation in Huntington\u2019s disease knock-in striatal cells. Free Radic Biol Med 53:1857\u20131867","journal-title":"Free Radic Biol Med"},{"key":"3_CR68","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1042\/BJ20111495","volume":"446","author":"JI Chae","year":"2012","unstructured":"Chae JI, Kim DW, Lee N, Jeon YJ, Jeon I, Kwon J, Kim J, Soh Y, Lee DS, Seo KS et al (2012) Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington\u2019s disease patient. Biochem J 446:359\u2013371","journal-title":"Biochem J"},{"key":"3_CR69","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1016\/j.bbamcr.2014.12.041","volume":"1853","author":"A Stotland","year":"2015","unstructured":"Stotland A, Gottlieb RA (2015) Mitochondrial quality control: easy come, easy go. Biochim Biophys Acta 1853:2802\u20132811","journal-title":"Biochim Biophys Acta"},{"key":"3_CR70","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.4161\/auto.24135","volume":"9","author":"J Zhu","year":"2013","unstructured":"Zhu J, Wang KZ, Chu CT (2013) After the banquet: mitochondrial biogenesis, mitophagy, and cell survival. Autophagy 9:1663\u20131676","journal-title":"Autophagy"},{"key":"3_CR71","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10863-010-9286-7","volume":"42","author":"YN Jin","year":"2010","unstructured":"Jin YN, Johnson GV (2010) The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease. J Bioenerg Biomembr 42:199\u2013205","journal-title":"J Bioenerg Biomembr"},{"key":"3_CR72","doi-asserted-by":"crossref","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM (2000) The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci USA 97:6763\u20136768","journal-title":"Proc Natl Acad Sci USA"},{"key":"3_CR73","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127:59\u201369","journal-title":"Cell"},{"key":"3_CR74","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.freeradbiomed.2013.04.016","volume":"62","author":"A Johri","year":"2013","unstructured":"Johri A, Chandra A, Beal MF (2013) PGC-1alpha, mitochondrial dysfunction, and Huntington\u2019s disease. Free Radic Biol Med 62:37\u201346","journal-title":"Free Radic Biol Med"},{"key":"3_CR75","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.exger.2014.01.021","volume":"56","author":"K Palikaras","year":"2014","unstructured":"Palikaras K, Tavernarakis N (2014) Mitochondrial homeostasis: the interplay between mitophagy and mitochondrial biogenesis. Exp Gerontol 56:182\u2013188","journal-title":"Exp Gerontol"},{"key":"3_CR76","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/hmg\/ddr475","volume":"21","author":"UP Shirendeb","year":"2012","unstructured":"Shirendeb UP, Calkins MJ, Manczak M, Anekonda V, Dufour B, McBride JL, Mao P, Reddy PH (2012) Mutant huntingtin\u2019s interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington\u2019s disease. Hum Mol Genet 21:406\u2013420","journal-title":"Hum Mol Genet"},{"key":"3_CR77","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","volume":"4","author":"P Weydt","year":"2006","unstructured":"Weydt P, Pineda VV, Torrence AE, Libby RT, Satterfield TF, Lazarowski ER, Gilbert ML, Morton GJ, Bammler TK, Strand AD et al (2006) Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC-1alpha in Huntington\u2019s disease neurodegeneration. Cell Metab 4:349\u2013362","journal-title":"Cell Metab"},{"key":"3_CR78","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nrm2275","volume":"8","author":"SA Detmer","year":"2007","unstructured":"Detmer SA, Chan DC (2007) Functions and dysfunctions of mitochondrial dynamics. Nat Rev Mol Cell Biol 8:870\u2013879","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3_CR79","unstructured":"Rosenstock TR, Brett AC, Rego AC (2012) Modified mitochondrial dynamics, turnover and function in neurodegeneration: a focus on Huntington\u2019s Disease. Cell Bioenerg Health Dis New Perspect Mitochondrial Biol, 149\u2013194"},{"key":"3_CR80","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","volume":"20","author":"U Shirendeb","year":"2011","unstructured":"Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, Tagle DA, Reddy PH (2011) Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington\u2019s disease: implications for selective neuronal damage. Hum Mol Genet 20:1438\u20131455","journal-title":"Hum Mol Genet"},{"key":"3_CR81","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bbadis.2011.10.016","volume":"1822","author":"PH Reddy","year":"2012","unstructured":"Reddy PH, Shirendeb UP (2012) Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington\u2019s disease. Biochim Biophys Acta 1822:101\u2013110","journal-title":"Biochim Biophys Acta"},{"key":"3_CR82","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrn2417","volume":"9","author":"AB Knott","year":"2008","unstructured":"Knott AB, Perkins G, Schwarzenbacher R, Bossy-Wetzel E (2008) Mitochondrial fragmentation in neurodegeneration. Nat Rev Neurosci 9:505\u2013518","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"3_CR83","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1091\/mbc.E12-10-0721","volume":"24","author":"O. C. Loson","year":"2013","unstructured":"Loson OC, Song Z, Chen H, Chan DC (2013) Fis1, Mff, MiD49, and MiD51 mediate Drp1 recruitment in mitochondrial fission. Mol Biol Cell 24(5):659\u2013667","journal-title":"Molecular Biology of the Cell"},{"key":"3_CR84","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbamcr.2006.02.003","volume":"1763","author":"EE Griffin","year":"2006","unstructured":"Griffin EE, Detmer SA, Chan DC (2006) Molecular mechanism of mitochondrial membrane fusion. Biochim Biophys Acta 1763:482\u2013489","journal-title":"Biochim Biophys Acta"},{"key":"3_CR85","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/emmm.201000102","volume":"2","author":"V Costa","year":"2010","unstructured":"Costa V, Giacomello M, Hudec R, Lopreiato R, Ermak G, Lim D, Malorni W, Davies KJ, Carafoli E, Scorrano L (2010) Mitochondrial fission and cristae disruption increase the response of cell models of Huntington\u2019s disease to apoptotic stimuli. EMBO Mol Med 2:490\u2013503","journal-title":"EMBO Mol Med"},{"key":"3_CR86","first-page":"107","volume":"48","author":"KE Zinsmaier","year":"2009","unstructured":"Zinsmaier KE, Babic M, Russo GJ (2009) Mitochondrial transport dynamics in axons and dendrites. Results Probl Cell Differ 48:107\u2013139","journal-title":"Results Probl Cell Differ"},{"key":"3_CR87","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.yexcr.2015.01.004","volume":"334","author":"MY Lin","year":"2015","unstructured":"Lin MY, Sheng ZH (2015) Regulation of mitochondrial transport in neurons. Exp Cell Res 334:35\u201344","journal-title":"Exp Cell Res"},{"key":"3_CR88","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1523\/JNEUROSCI.0106-08.2008","volume":"28","author":"AL Orr","year":"2008","unstructured":"Orr AL, Li S, Wang CE, Li H, Wang J, Rong J, Xu X, Mastroberardino PG, Greenamyre JT, Li XJ (2008) N-terminal mutant huntingtin associates with mitochondria and impairs mitochondrial trafficking. J Neurosci Off J Soc Neurosci 28:2783\u20132792","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"3_CR89","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","volume":"24","author":"E Trushina","year":"2004","unstructured":"Trushina E, Dyer RB, Badger JD 2nd, Ure D, Eide L, Tran DD, Vrieze BT, Legendre-Guillemin V, McPherson PS, Mandavilli BS et al (2004) Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 24:8195\u20138209","journal-title":"Mol Cell Biol"},{"issue":"2","key":"3_CR90","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.nbd.2005.12.007","volume":"22","author":"Diane T.W. Chang","year":"2006","unstructured":"Chang TWD, Rintoul GL, Pandipati S, Reynolds IJ (2006) Mutant huntingtin aggregates impair mitochondrial movement and trafficking in cortical neurons. Neurobiol Dis 22(2):388\u2013400","journal-title":"Neurobiology of Disease"},{"key":"3_CR91","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1089\/ars.2010.3779","volume":"14","author":"G Twig","year":"2011","unstructured":"Twig G, Shirihai OS (2011) The interplay between mitochondrial dynamics and mitophagy. Antioxid Redox Signal 14:1939\u20131951","journal-title":"Antioxid Redox Signal"},{"key":"3_CR92","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/embor.2013.168","volume":"14","author":"GF Allen","year":"2013","unstructured":"Allen GF, Toth R, James J, Ganley IG (2013) Loss of iron triggers PINK1\/Parkin-independent mitophagy. EMBO Rep 14:1127\u20131135","journal-title":"EMBO Rep"},{"key":"3_CR93","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/cdd.2014.190","volume":"22","author":"F Strappazzon","year":"2015","unstructured":"Strappazzon F, Nazio F, Corrado M, Cianfanelli V, Romagnoli A, Fimia GM, Campello S, Nardacci R, Piacentini M, Campanella M et al (2015) AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62\/SQSTM1. Cell Death Differ 22:517","journal-title":"Cell Death Differ"},{"key":"3_CR94","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/ncb2837","volume":"15","author":"CT Chu","year":"2013","unstructured":"Chu CT, Ji J, Dagda RK, Jiang JF, Tyurina YY, Kapralov AA, Tyurin VA, Yanamala N, Shrivastava IH, Mohammadyani D et al (2013) Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat Cell Biol 15:1197\u20131205","journal-title":"Nat Cell Biol"},{"key":"3_CR95","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/hmg\/ddq526","volume":"20","author":"E Deas","year":"2011","unstructured":"Deas E, Plun-Favreau H, Gandhi S, Desmond H, Kjaer S, Loh SH, Renton AE, Harvey RJ, Whitworth AJ, Martins LM et al (2011) PINK1 cleavage at position A103 by the mitochondrial protease PARL. Hum Mol Genet 20:867\u2013879","journal-title":"Hum Mol Genet"},{"key":"3_CR96","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/embor.2012.14","volume":"13","author":"AW Greene","year":"2012","unstructured":"Greene AW, Grenier K, Aguileta MA, Muise S, Farazifard R, Haque ME, McBride HM, Park DS, Fon EA (2012) Mitochondrial processing peptidase regulates PINK1 processing, import and Parkin recruitment. EMBO Rep 13:378\u2013385","journal-title":"EMBO Rep"},{"key":"3_CR97","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1242\/jcs.161000","volume":"128","author":"K Okatsu","year":"2015","unstructured":"Okatsu K, Kimura M, Oka T, Tanaka K, Matsuda N (2015) Unconventional PINK1 localization to the outer membrane of depolarized mitochondria drives Parkin recruitment. J Cell Sci 128:964\u2013978","journal-title":"J Cell Sci"},{"key":"3_CR98","doi-asserted-by":"crossref","first-page":"939","DOI":"10.15252\/embr.201540352","volume":"16","author":"A Kazlauskaite","year":"2015","unstructured":"Kazlauskaite A, Martinez-Torres RJ, Wilkie S, Kumar A, Peltier J, Gonzalez A, Johnson C, Zhang J, Hope AG, Peggie M et al (2015) Binding to serine 65-phosphorylated ubiquitin primes Parkin for optimal PINK1-dependent phosphorylation and activation. EMBO Rep 16:939\u2013954","journal-title":"EMBO Rep"},{"key":"3_CR99","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1083\/jcb.200809125","volume":"183","author":"D Narendra","year":"2008","unstructured":"Narendra D, Tanaka A, Suen DF, Youle RJ (2008) Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183:795\u2013803","journal-title":"J Cell Biol"},{"key":"3_CR100","doi-asserted-by":"crossref","first-page":"e1617","DOI":"10.1038\/cddis.2014.581","volume":"6","author":"B Khalil","year":"2015","unstructured":"Khalil B, El Fissi N, Aouane A, Cabirol-Pol MJ, Rival T, Lievens JC (2015) PINK1-induced mitophagy promotes neuroprotection in Huntington\u2019s disease. Cell Death Dis 6:e1617","journal-title":"Cell Death Dis"},{"key":"3_CR101","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1523\/JNEUROSCI.1870-13.2014","volume":"34","author":"YC Wong","year":"2014","unstructured":"Wong YC, Holzbaur EL (2014) The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation. J Neurosci Off J Soc Neurosci 34:1293\u20131305","journal-title":"J Neurosci Off J Soc Neurosci"},{"key":"3_CR102","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ncb3101","volume":"17","author":"YN Rui","year":"2015","unstructured":"Rui YN, Xu Z, Patel B, Chen Z, Chen D, Tito A, David G, Sun Y, Stimming EF, Bellen HJ et al (2015) Huntingtin functions as a scaffold for selective macroautophagy. Nat Cell Biol 17:262\u2013275","journal-title":"Nat Cell Biol"},{"key":"3_CR103","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.molcel.2015.10.009","volume":"60","author":"N Sun","year":"2015","unstructured":"Sun N, Yun J, Liu J, Malide D, Liu C, Rovira II, Holmstrom KM, Fergusson MM, Yoo YH, Combs CA et al (2015) Measuring In Vivo Mitophagy. Mol Cell 60:685\u2013696","journal-title":"Mol Cell"},{"key":"3_CR104","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ceb.2003.10.004","volume":"15","author":"T Kuwana","year":"2003","unstructured":"Kuwana T, Newmeyer DD (2003) Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol 15:691\u2013699","journal-title":"Curr Opin Cell Biol"},{"key":"3_CR105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1042\/bse0470099","volume":"47","author":"MJ Parsons","year":"2010","unstructured":"Parsons MJ, Green DR (2010) Mitochondria in cell death. Essays Biochem 47:99\u2013114","journal-title":"Essays Biochem"},{"key":"3_CR106","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1242\/jcs.099234","volume":"125","author":"SW Tait","year":"2012","unstructured":"Tait SW, Green DR (2012) Mitochondria and cell signalling. J Cell Sci 125:807\u2013815","journal-title":"J Cell Sci"},{"key":"3_CR107","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bbrc.2005.03.149","volume":"331","author":"C Culmsee","year":"2005","unstructured":"Culmsee C, Mattson MP (2005) p53 in neuronal apoptosis. Biochem Biophys Res Commun 331:761\u2013777","journal-title":"Biochem Biophys Res Commun"},{"key":"3_CR108","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nbd.2008.01.015","volume":"30","author":"W Duan","year":"2008","unstructured":"Duan W, Peng Q, Masuda N, Ford E, Tryggestad E, Ladenheim B, Zhao M, Cadet JL, Wong J, Ross CA (2008) Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington\u2019s disease. Neurobiol Dis 30:312\u2013322","journal-title":"Neurobiol Dis"},{"key":"3_CR109","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1083\/jcb.201105010","volume":"194","author":"TC Ju","year":"2011","unstructured":"Ju TC, Chen HM, Lin JT, Chang CP, Chang WC, Kang JJ, Sun CP, Tao MH, Tu PH, Chang C et al (2011) Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington\u2019s disease. J Cell Biol 194:209\u2013227","journal-title":"J Cell Biol"},{"key":"3_CR110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1179\/174313208X331572","volume":"31","author":"PJ Kong","year":"2009","unstructured":"Kong PJ, Kil MO, Lee H, Kim SS, Johnson GV, Chun W (2009) Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington\u2019s disease knock-in striatal cell line. Neurol Res 31:77\u201383","journal-title":"Neurol Res"},{"key":"3_CR111","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1460-9568.2010.07215.x","volume":"31","author":"R Leon","year":"2010","unstructured":"Leon R, Bhagavatula N, Ulukpo O, McCollum M, Wei J (2010) BimEL as a possible molecular link between proteasome dysfunction and cell death induced by mutant huntingtin. Eur J Neurosci 31:1915\u20131925","journal-title":"Eur J Neurosci"},{"key":"3_CR112","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1038\/cddis.2009.6","volume":"1","author":"J Sassone","year":"2010","unstructured":"Sassone J, Colciago C, Marchi P, Ascardi C, Alberti L, Di Pardo A, Zippel R, Sipione S, Silani V, Ciammola A (2010) Mutant Huntingtin induces activation of the Bcl-2\/adenovirus E1B 19-kDa interacting protein (BNip3). Cell Death Dis 1:e7","journal-title":"Cell Death Dis"},{"key":"3_CR113","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1002\/jnr.21258","volume":"85","author":"JM Garcia-Martinez","year":"2007","unstructured":"Garcia-Martinez JM, Perez-Navarro E, Xifro X, Canals JM, Diaz-Hernandez M, Trioulier Y, Brouillet E, Lucas JJ, Alberch J (2007) BH3-only proteins Bid and Bim(EL) are differentially involved in neuronal dysfunction in mouse models of Huntington\u2019s disease. J Neurosci Res 85:2756\u20132769","journal-title":"J Neurosci Res"},{"key":"3_CR114","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1046\/j.1471-4159.2001.00482.x","volume":"78","author":"O Hansson","year":"2001","unstructured":"Hansson O, Castilho RF, Korhonen L, Lindholm D, Bates GP, Brundin P (2001) Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington\u2019s disease is dependent on age and CAG repeat length. J Neurochem 78:694\u2013703","journal-title":"J Neurochem"},{"key":"3_CR115","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neulet.2008.03.062","volume":"438","author":"AV Teles","year":"2008","unstructured":"Teles AV, Rosenstock TR, Okuno CS, Lopes GS, Bertoncini CR, Smaili SS (2008) Increase in bax expression and apoptosis are associated in Huntington\u2019s disease progression. Neurosci Lett 438:59\u201363","journal-title":"Neurosci Lett"},{"key":"3_CR116","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/hmg\/ddq322","volume":"19","author":"MC Chiang","year":"2010","unstructured":"Chiang MC, Chen CM, Lee MR, Chen HW, Chen HM, Wu YS, Hung CH, Kang JJ, Chang CP, Chang C et al (2010) Modulation of energy deficiency in Huntington\u2019s disease via activation of the peroxisome proliferator-activated receptor gamma. Hum Mol Genet 19:4043\u20134058","journal-title":"Hum Mol Genet"},{"key":"3_CR117","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1046\/j.1471-4159.2003.02105.x","volume":"87","author":"Y Zhang","year":"2003","unstructured":"Zhang Y, Ona VO, Li M, Drozda M, Dubois-Dauphin M, Przedborski S, Ferrante RJ, Friedlander RM (2003) Sequential activation of individual caspases, and of alterations in Bcl-2 proapoptotic signals in a mouse model of Huntington\u2019s disease. J Neurochem 87:1184\u20131192","journal-title":"J Neurochem"},{"key":"3_CR118","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.phrs.2005.01.006","volume":"52","author":"D Goffredo","year":"2005","unstructured":"Goffredo D, Rigamonti D, Zuccato C, Tartari M, Valenza M, Cattaneo E (2005) Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington\u2019s Disease. Pharmacol Res 52:140\u2013150","journal-title":"Pharmacol Res"},{"key":"3_CR119","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.neuint.2011.04.009","volume":"59","author":"TR Rosenstock","year":"2011","unstructured":"Rosenstock TR, de Brito OM, Lombardi V, Louros S, Ribeiro M, Almeida S, Ferreira IL, Oliveira CR, Rego AC (2011) FK506 ameliorates cell death features in Huntington\u2019s disease striatal cell models. Neurochem Int 59:600\u2013609","journal-title":"Neurochem Int"},{"key":"3_CR120","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00401-004-0957-5","volume":"109","author":"JC Vis","year":"2005","unstructured":"Vis JC, Schipper E, de Boer-van Huizen RT, Verbeek MM, de Waal RM, Wesseling P, ten Donkelaar HJ, Kremer B (2005) Expression pattern of apoptosis-related markers in Huntington\u2019s disease. Acta Neuropathol 109:321\u2013328","journal-title":"Acta Neuropathol"},{"key":"3_CR121","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1038\/sj.cdd.4401967","volume":"13","author":"A Ciammola","year":"2006","unstructured":"Ciammola A, Sassone J, Alberti L, Meola G, Mancinelli E, Russo MA, Squitieri F, Silani V (2006) Increased apoptosis, Huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington\u2019s disease subjects. Cell Death Differ 13:2068\u20132078","journal-title":"Cell Death Differ"},{"key":"3_CR122","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1523\/JNEUROSCI.2071-10.2010","volume":"30","author":"RK Graham","year":"2010","unstructured":"Graham RK, Deng Y, Carroll J, Vaid K, Cowan C, Pouladi MA, Metzler M, Bissada N, Wang L, Faull RL et al (2010) Cleavage at the 586 amino acid caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo. J Neurosci 30:15019\u201315029","journal-title":"J Neurosci"},{"key":"3_CR123","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.cell.2006.04.026","volume":"125","author":"RK Graham","year":"2006","unstructured":"Graham RK, Deng Y, Slow EJ, Haigh B, Bissada N, Lu G, Pearson J, Shehadeh J, Bertram L, Murphy Z et al (2006) Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell 125:1179\u20131191","journal-title":"Cell"},{"key":"3_CR124","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/sj.cdd.4401358","volume":"11","author":"E Hermel","year":"2004","unstructured":"Hermel E, Gafni J, Propp SS, Leavitt BR, Wellington CL, Young JE, Hackam AS, Logvinova AV, Peel AL, Chen SF et al (2004) Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington\u2019s disease. Cell Death Differ 11:424\u2013438","journal-title":"Cell Death Differ"},{"key":"3_CR125","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1093\/hmg\/ddn139","volume":"17","author":"SC Warby","year":"2008","unstructured":"Warby SC, Doty CN, Graham RK, Carroll JB, Yang YZ, Singaraja RR, Overall CM, Hayden MR (2008) Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus. Hum Mol Genet 17:2390\u20132404","journal-title":"Hum Mol Genet"},{"key":"3_CR126","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/hmg\/ddr176","volume":"20","author":"AT Tebbenkamp","year":"2011","unstructured":"Tebbenkamp AT, Green C, Xu G, Denovan-Wright EM, Rising AC, Fromholt SE, Brown HH, Swing D, Mandel RJ, Tessarollo L et al (2011) Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative. Hum Mol Genet 20:2770\u20132782","journal-title":"Hum Mol Genet"},{"key":"3_CR127","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1523\/JNEUROSCI.1305-11.2012","volume":"32","author":"E Waldron-Roby","year":"2012","unstructured":"Waldron-Roby E, Ratovitski T, Wang X, Jiang M, Watkin E, Arbez N, Graham RK, Hayden MR, Hou Z, Mori S et al (2012) Transgenic mouse model expressing the caspase 6 fragment of mutant huntingtin. J Neurosci 32:183\u2013193","journal-title":"J Neurosci"},{"key":"3_CR128","doi-asserted-by":"crossref","first-page":"7454","DOI":"10.1523\/JNEUROSCI.6379-11.2012","volume":"32","author":"J Gafni","year":"2012","unstructured":"Gafni J, Papanikolaou T, Degiacomo F, Holcomb J, Chen S, Menalled L, Kudwa A, Fitzpatrick J, Miller S, Ramboz S et al (2012) Caspase-6 activity in a BACHD mouse modulates steady-state levels of mutant huntingtin protein but is not necessary for production of a 586 amino acid proteolytic fragment. J Neurosci 32:7454\u20137465","journal-title":"J Neurosci"},{"key":"3_CR129","first-page":"e4fd085bfc9973","volume":"4","author":"Christian Landles","year":"2012","unstructured":"Landles C, Weiss A, Franklin S, Howland D, Bates G (2012) Caspase-6 does not contribute to the proteolysis of mutant huntingtin in the HdhQ150 knock-in mouse model of Huntington\u2019s disease. PLoS Curr 4, e4fd085bfc9973","journal-title":"PLoS Currents"}],"container-title":["Advances in Experimental Medicine and Biology","Polyglutamine Disorders"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-71779-1_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T02:48:56Z","timestamp":1719802136000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-71779-1_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319717784","9783319717791"],"references-count":129,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-71779-1_3","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}